Guidelines endorsed by RCPCH - Nephrology
The College reviews high quality guidelines and standards produced and published by other organisations against the RCPCH Standards for Endorsement. We believe the following publications will be of interest to paediatricians working in nephrology.
The following have been endorsed by the College.
- Anaemia Management in Chronic Kidney Disease (NICE) - 2015
- Anaemia Management In Chronic Kidney Disease (NICE) - 2011
- Hypertension in Pregnancy (NICE)
- Investigations in Hypernatraemia (RCPCH)
- Neonatal Jaundice (NICE)
- Nocturnal Enuresis (NICE)
- Organ Donation for Transplantation (NICE)
- Paediatric Continence Commissioning Guide (PCF)
- Urinary Tract Infection in Febrile Infants and Young Children (AAP)
- Urinary Tract Infection in Children (NICE)
Urinary tract Infection in Infants, Children and Young People Under 16 (NICE)
Anaemia is defined as a state in which the quality or quantity of circulating red blood cells is below normal. Blood haemoglobin (Hb) concentration serves as the key indicator for anaemia because it can be measured directly and has an international standard. A major cause of anaemia of chronic kidney disease (CKD) is a reduction in erythropoietin production due to kidney damage. Erythropoietin stimulates the bone marrow to produce red blood cells, and it is produced by the kidney in response to low tissue oxygen levels.
This guideline covers the management of anaemia in adults, children and young people with a clinical diagnosis of anaemia associated with CKD.
Date of Publication: June 2015
Endorsed on: October 2015
Full guideline (PDF, 4,382KB, 324 Pages)
This clinical guideline (Feb 2011) updates and replaces NICE clinical guideline 39 (published September 2006). It covers the detection and diagnosis of individuals with a suspected clinical diagnosis of anaemia associated with Chronic Kidney Disease (CKD) and their subsequent management. The guideline contains updated recommendations on the diagnostic role of Hb levels and Optimal Hb levels.
Date of Publication: January 2011
Date of Endorsement: February 2011
The guideline covers the diagnosis and management of hypertensive disorders during the antenatal, intrapartum and postnatal periods. It also contains recommendations for advice to women who wish to conceive and suffer from chronic hypertension, as well as advice to women after a pregnancy complicated by hypertension.
The guideline is accompanied by a quick reference guide, guidance for patients and carers, audit support, a costing report, a baseline assessment tool, a slide set and a costing template.
Date of Publication: August 2010
Date Endorsed: October 2010
This guideline is based on a systematic review of the literature relating to hypernatraemia and salt poisoning. It will provide evidence-based guidance on the differential diagnoses for hypernatraemia in children and on what investigations should be undertaken when children present, and the interpretation of the results of investigations.
The guideline is accompanied by an executive summary.
Date of Publication: July 2009
Date of Endorsement: April 2009
RCPCH guideline (PDF, 0.99KB, 114 Pages)
The guideline covers the recognition, assessment and treatment of neonatal jaundice as well as the prediction of later significant hyperbilirubinaemia and adverse sequelae in babies from birth until 28 days of age.
The guideline is accompanied by a quick reference guide, guidance for parents and carers, audit support tools, costing tools, a factsheet, treatment threshold graphs, a slide set and a baseline assessment tool.
The RCPCH welcomes the publication of this guideline but asks Members to note the following:
- The scope of the guideline does not cover infants with jaundice lasting beyond the first 28 days.
Date of Publication: May 2010
Date of Endorsement: June 2010
This guideline covers recommendations for the management of night time bedwetting, with or without daytime urinary, in children under the age of 19, with or without special needs.
The guideline is accompanied by guidance for patients and carers, audit support, a costing statement, a baseline assessment tool, costing template and slide side.
Date of Publication: October 2010
Date of Endorsement: October 2010
This guideline recognises the complexities that arise owing to the majority of potential adult and paediatric organ donors lacking the capacity to be directly involved in decision making at the time of their death. It covers strategies for improving donor identification and consent rates for deceased organ donation.
The College asks members to note that:
- There are few data on the validity of trigger tools in paediatric practice. NICE’s response to this comment is as follows: ‘The GDG made their decisions using the best available evidence, and where this was not available or lacking, the GDG based their recommendations on their clinical experience.’ It should be noted that NICE has deemed the best evidence from studies investigating conversion of patients displaying clinical triggers into organ donors is of very low quality.
- Explicit reference to contraindications to donation from a paediatric perspective is not covered by the guideline. This is because the GDG agreed that contraindications should not be included due to the rapid pace at which changes to contraindications occur particularly in paediatric patients.
Date of Publication: December 2011
Date of Endorsement: February 2012
The Paediatric Continence Commissioning Guide is a resource to assist commissioners, clinicians and managers to deliver integrated and evidence-based community paediatric continence services that meet the needs of children and young people with continence difficulties (bladder and bowel dysfunction) across England.
Its aim is to improve the health and wellbeing of these children and young people through supporting local service redesign that is high quality and cost effective and takes into account patient experience.
Date of Publiction: September 2014
Date of Endorsement: September 2014
Full guideline (PDF, 1.11 MB, 41 Pages)
The aim of the guideline was to formulate recommendations for health care professionals about the diagnosis, treatment, and evaluation of an initial urinary tract infection (UTI) in febrile infants and young children ages 2 months to 2 years.
The guideline includes an algorithm.
This guideline will be updated in 2009 by the American Academy of Pediatrics.
Date of Publication: April 1999
Date of Endorsement: April 1999
Technical report (PDF, 990KB, 60 Pages)
The guideline covers the investigations and treatment for children younger than 16 years who have a urinary tract infection (UTI) and the information that should be offered to their families. Urine testing strategies are provided. The guideline is particularly relevant to all healthcare professionals who are involved in providing care for children who have a UTI, those responsible for commissioning and planning healthcare services and children who have a UTI and their families.
The guideline includes key priorities for implementation, a quick reference guide, information for parents/carers, slides highlighting the key messages, audit criteria, costing tools, implementation advice, and an online educational tool.
Date of Publication: August 2007
Date of Endorsement: March 2008
This quality standard covers the care of infants, children and young people under 16 years with a first or recurrent upper or lower urinary tract infection and without known underlying uropathy.
Date of Publication: July 2013
Date of Endorsement: October 2013
(PDF, 170KB, 31 Pages)